Investor Presentaiton
Novo Nordisk Annual Report 2023
Management
review
Introducing Novo Nordisk
Strategic Aspirations
Risks
Management
Consolidated statements
Additional information
2
Consolidated statements
and additional information
3
Introducing Novo Nordisk
50
4
Letter from the Chair and the CEO
50
6
Novo Nordisk at a glance
7
Our value creation
8
Performance highlights
10 Strategic Aspirations
11
Purpose and sustainability
23 Innovation and therapeutic focus
30 Commercial execution
34
Financials
Consolidated financial statements
Income statement and Statement
of comprehensive income
51
Cash flow statement
52 Balance sheet
53
Equity statement
54 Notes to the consolidated
financial statements
86
86
80 80 80
Consolidated ESG statement
Statement of ESG performance
87 Notes to the consolidated
ESG statement
95 Statements and Auditor's Reports
Statement by the Board of Directors
95
and Executive Management
Independent Auditor's Report
Independent Assurance Report
on the ESG statement
40
Risks
41
Risk management
42
Key operational risks
244
43
Management
44
Board of Directors
96
47
Executive Management
98
99
Additional information
100 More information
101
Product overview
102 ESG initiatives
104 Sustainability frameworks and performance
00886
Participants at the Future
Scientists Summer Camp,
organised by Novo Nordisk
and the LIFE Foundation to
celebrate Novo Nordisk's
100-year anniversary in 2023.View entire presentation